AbbVie

From WikiMD's WELLNESSPEDIA

(Redirected from AbbVie Inc.)

AbbVie Inc. is a prominent biopharmaceutical company based in the United States that was publicly traded and established in 2013. The company's inception stemmed from its spin-off from the renowned Abbott Laboratories.

File:AbbVie logo.svg
AbbVie Logo

Background[edit]

AbbVie's establishment in 2013 was a strategic move by Abbott Laboratories to separate its research-driven pharmaceutical business from its diversified medical products. The decision to spin off AbbVie aimed at allowing both entities to focus more exclusively on their individual business strategies and growth potentials.

Core Areas of Focus[edit]

AbbVie is committed to harnessing groundbreaking science to tackle some of the world's most complex and critical health challenges. Its primary areas of therapeutic focus include:

The company consistently invests in robust R&D initiatives to propel the boundaries of medicine and offer promising treatment avenues.

Notable Products[edit]

File:Autoinjector with Amgevita by Amgen (Adalimumab)-6391.jpg
Autoinjector with Amgevita by Amgen

AbbVie's portfolio boasts several groundbreaking and life-transforming drugs. Some of its flagship products include:

Global Presence[edit]

With a commitment to addressing complex health challenges, AbbVie has expanded its reach across the globe. It conducts business in more than 75 countries, ensuring that its life-saving treatments are accessible to patients worldwide.

Corporate Social Responsibility[edit]

Driven by its mission to have a remarkable impact on people's lives, AbbVie is heavily invested in community-centric programs, sustainable business practices, and initiatives aimed at reducing its carbon footprint.

See Also[edit]

References[edit]